Researchers at the University of Texas Medical Branch have discovered the basis of a new medication that could change treatment for latent HIV in patients using anti-retroviral medication regimens and could ultimately lead to a treatment that puts the virus in remission.

“We are in the pre-clinical stage, proving a concept,” said Dr. Haitao Hu, the study’s principal investigator and assistant professor in the Department of Microbiology and Immunology at the medical branch. “The drug we’re proposing works with a certain protein in the body, BRD4, to cause the HIV virus to stop from harming the body again.”

Kathryn Eastburn: 409-683-5257;

(1) comment

Jeff Patterson


Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Thank you for Reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.